AI Strategy — Travant Consulting

What we do

We work alongside pharma and emerging pharma commercial leadership as a long-term AI strategy partner — helping organisations assess readiness, prioritise use cases, establish governance, and build the internal capability to sustain AI-driven value beyond the pilot phase. We bring the commercial domain knowledge to ensure AI investments are grounded in business reality, and the strategic independence to evaluate options without a platform or implementation revenue agenda.

Specific offerings

Commercial AI Readiness Assessment

An honest diagnostic of where your organisation currently stands across data infrastructure, internal capability, governance maturity, and commercial use case readiness. The output is a clear-eyed view of where AI is likely to generate near-term commercial value — and where it is likely to stall — with a prioritised roadmap for closing the gaps that matter most.

AI Use Case Prioritisation

We work with commercial leadership to evaluate candidate AI use cases across targeting, forecasting, content operations, omnichannel engagement, and market access — scored by commercial value, implementation feasibility, regulatory risk, and data availability. The output is an investment-grade use case portfolio, not a wish list.

AI Governance & Compliance Framework

Pharma is a regulated environment, and AI deployments that are not governed correctly create promotional compliance, data privacy, and MLR risk. We design the policies, review workflows, documentation standards, and guardrails that allow AI to be deployed responsibly — with human-in-the-loop oversight built in from the start.

Generative AI in Commercial Operations

We support the practical deployment of generative AI capabilities in content generation, MLR pre-screening workflows, competitive intelligence synthesis, and field communication support — with a clear focus on where generative AI reduces genuine operational cost and where it introduces unacceptable accuracy or compliance risk.

Agentic AI for Field & Marketing Teams

Next-best-action systems, dynamic call planning, and personalised HCP engagement at scale are among the most commercially valuable AI applications in pharma. We provide strategy and independent oversight for agentic AI deployments — covering use case design, vendor evaluation, model validation, and adoption planning — without the conflict of interest of a platform vendor.

AI Capability Building & Internal Adoption

The gap between AI pilots and commercially embedded AI use is almost always an organisational and capability challenge, not a technical one. We design the training, change management, and governance infrastructure that enables commercial teams to adopt AI tools effectively — turning pilot results into sustained operational practice.

← All services

AI-enabled capability

This practice area is itself AI-augmented. We use current AI capabilities to accelerate competitive scanning, use case modelling, governance documentation, and analytical synthesis. Every recommendation is validated by senior practitioners with direct pharma commercial experience — the combination of AI-assisted analysis and domain-grounded judgment is deliberate.

Related case study

AI Strategy

AI Use Case Prioritisation for a Specialty Pharma Commercial Team

Context

A specialty pharma company's commercial leadership team was under pressure from the board to develop an AI strategy. Multiple vendors were pitching platforms and point solutions, but the team lacked the internal clarity to evaluate competing claims or prioritise investment against commercial objectives.

Approach

We led a structured AI strategy engagement — beginning with a commercial AI readiness assessment across data infrastructure, capability, and governance. We then facilitated an AI use case prioritisation process with cross-functional commercial leadership, scoring 14 candidate use cases against commercial value, feasibility, and risk. The process produced a sequenced AI investment roadmap and a governance framework for the first phase of deployment.

Outcome

The commercial team entered vendor conversations with a clear use case brief, defined evaluation criteria, and a governance framework — significantly improving the quality of vendor assessments and the confidence of investment decisions. The prioritised roadmap aligned commercial, IT, and finance leadership around a shared AI investment thesis for the first time.

See all case studies →